| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2081513 | Drug Discovery Today | 2011 | 7 Pages |
Abstract
Clusters are groups of co-located and interconnected firms and institutions linked by commonalities in their strategies and complementarities in their activities and resources. There are several reasons for the geographical clustering of firms in the biopharmaceutical industry. This review unpacks some advantages and disadvantages of cluster participation, and proposes a new method to enable managers and researchers to identify clusters in the biopharmaceutical industry.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Zeynep Erden, Georg von Krogh,